Voafotsy — Hermetica Encyclopedia
Herb · African

Voafotsy (Pterocarpus tinctorius)

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Voafotsy bark and heartwood contain phenolics, flavonoids, tannins, stilbenoids, and saponins that exert antioxidant, antimicrobial, and anti-inflammatory activities through free radical scavenging and membrane disruption of pathogens. In vitro methanolic bark extracts have demonstrated antibacterial activity against clinically relevant pathogens, though no human clinical trials have yet quantified effect sizes or therapeutic doses.

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordVoafotsy benefits
Voafotsy close-up macro showing natural texture and detail — rich in antimicrobial, antioxidant, stress
Voafotsy — botanical close-up

Health Benefits

**Wound Healing Support**
Tannins and phenolic compounds in the bark form a protective astringent layer over wounds, reducing microbial colonization and supporting tissue repair through protein precipitation and barrier reinforcement.
**Antimicrobial Activity**
Methanolic bark extracts inhibit growth of bacterial pathogens in laboratory assays, attributed to flavonoid and phenolic subfractions that disrupt cell membrane integrity and inhibit essential microbial enzymes.
**Antioxidant Protection**
Flavonoids and stilbenoids act as electron donors to neutralize reactive oxygen species, potentially reducing oxidative stress-related cellular damage in affected tissues.
**Anti-inflammatory Potential**: Saponins and polyphenols in P
tinctorius are structurally analogous to compounds in related Pterocarpus species shown to inhibit pro-inflammatory enzyme pathways, suggesting similar cyclooxygenase or lipoxygenase modulation.
**Antifungal Properties**
Traditional use for skin infections and phytochemical profiles rich in saponins align with documented antifungal mechanisms—saponin complexation with membrane sterols disrupts fungal cell integrity.
**Hepatoprotective Potential**
Broader Pterocarpus genus research documents hepatoprotective activity linked to flavonoid-mediated reduction of lipid peroxidation and stabilization of hepatocyte membrane enzymes, a plausible overlap for P. tinctorius.
**Anthelmintic Use**
Regional ethnobotanical records note use against parasitic infections, consistent with saponin-rich extracts that exhibit surface-active cytotoxicity toward helminth teguments in related species.

Origin & History

Voafotsy growing in Africa — natural habitat
Natural habitat

Pterocarpus tinctorius is a deciduous tree native to sub-Saharan Africa and Madagascar, where it grows in woodland savannas, miombo forests, and dry-to-moist transitional zones at low to moderate elevations. In Madagascar it is commonly called Voafotsy and thrives in the island's western dry forests and disturbed secondary vegetation. The tree is not widely cultivated commercially; bark and heartwood are harvested from wild specimens by local communities for medicinal and dyeing purposes.

Pterocarpus tinctorius holds ethnobotanical significance across sub-Saharan Africa and Madagascar, where communities have used its bark, heartwood, and root preparations for generations to treat infected wounds, skin conditions, and inflammatory disorders. In Madagascar, the plant is known as Voafotsy and occupies a place in traditional healing practice alongside other indigenous botanicals, with healers preparing bark decoctions applied directly to lesions to reduce infection and promote closure. Across mainland Africa, related Pterocarpus species have been documented in Zambian, Angolan, and Congolese traditional medicine systems for anti-inflammatory and antiparasitic purposes, reflecting a consistent regional pharmacopeia built around this genus. The species also has a historic role as a natural dye source—its name tinctorius derives from the Latin for 'used in dyeing'—indicating dual utility as both a medicinal and craft material in local cultures.Traditional Medicine

Scientific Research

Published research on Pterocarpus tinctorius is limited to in vitro phytochemical screening and antibacterial bioassay studies, with no randomized controlled trials, animal pharmacokinetic studies, or human clinical investigations identified in peer-reviewed databases as of the current review. Available laboratory studies employ crude methanolic extracts and column-separated subfractions tested against bacterial strains using disk diffusion or broth microdilution methods, yielding qualitative inhibition data without minimum inhibitory concentration values consistently reported. Broader genus-level evidence from P. erinaceus and P. angolensis provides indirect phytochemical context, including triterpenoid and sterol isolation with documented anti-inflammatory activity in rodent models, but these findings cannot be directly extrapolated to P. tinctorius without species-specific validation. The overall body of evidence is sparse, methodologically preliminary, and insufficient to draw conclusions about clinical efficacy, optimal dosing, or comparative effectiveness relative to standard wound-care interventions.

Preparation & Dosage

Voafotsy prepared as liquid extract — pairs with In traditional wound-care contexts, Voafotsy bark preparations are often combined with other antimicrobial botanical ingredients such as Aloe vera gel or honey-based carriers, where the astringent tannins of P. tinctorius may complement the humectant and barrier-forming properties of these co-ingredients to enhance wound closure outcomes. The flavonoid content of P. tinctorius could theoretically synergize with vitamin C
Traditional preparation
**Traditional Bark Decoction**
Bark pieces are boiled in water for 15–30 minutes and the resulting liquid is applied topically to wounds or consumed orally; no standardized volume or concentration is established.
**Traditional Heartwood Infusion**
Shaved heartwood is steeped in hot water or alcohol and used topically as an antiseptic wash in Malagasy folk medicine; preparation ratios are empirical and community-specific.
**Methanolic Extract (Laboratory Grade)**
Research studies use crude methanolic extraction at unspecified plant-to-solvent ratios for in vitro bioassay only; not suitable for human use without further processing and safety testing.
**No Standardized Commercial Supplement Form**
No capsule, tablet, tincture, or standardized extract of P. tinctorius is commercially available with documented phytochemical standardization percentages.
**Effective Human Dose**
Undetermined; no clinical dosing studies have been performed and extrapolation from in vitro data to human doses is not scientifically validated.

Nutritional Profile

Pterocarpus tinctorius bark and heartwood are not consumed as a dietary food source and therefore lack a conventional macronutrient profile (proteins, fats, carbohydrates) relevant to nutrition. Phytochemical screening confirms the presence of phenolic compounds, flavonoids, tannins, stilbenoids, and saponins as the primary bioactive constituents, though quantitative concentrations expressed in µg/g or mg/100g have not been reported for this species. Related Pterocarpus species contain triterpenoids such as friedelin and 3α-hydroxyfriedelan-2-one, sterols including stigmasterol, and glycosides such as maltol-6''-O-apiofuranoside-glucopyranoside, suggesting P. tinctorius may harbor structurally analogous compounds. Bioavailability of these compound classes from crude preparations is expected to be variable and dependent on extraction solvent polarity, preparation method, and matrix effects from co-present tannins that may bind and reduce absorption of other phytochemicals.

How It Works

Mechanism of Action

The phenolic and flavonoid constituents of Pterocarpus tinctorius extracts are understood to scavenge free radicals by donating hydrogen atoms to reactive oxygen and nitrogen species, thereby interrupting oxidative chain reactions at the cellular level. Tannins exert antimicrobial effects by precipitating bacterial surface proteins and binding to lipopolysaccharide components of gram-negative bacterial membranes, increasing permeability and causing cytoplasmic leakage. Saponins, owing to their amphiphilic structure combining a hydrophilic sugar moiety with a lipophilic triterpenoid or steroidal aglycone, intercalate into pathogen and fungal membranes, forming pores that collapse transmembrane gradients. While no receptor-level or gene-expression studies have been conducted specifically on P. tinctorius, analogy to structurally characterized compounds from P. erinaceus—including friedelin and stigmasterol—suggests possible inhibition of NF-κB inflammatory signaling and modulation of COX-2 enzyme activity.

Clinical Evidence

No clinical trials have been conducted on Pterocarpus tinctorius in any therapeutic indication, including its primary traditional use as a wound-healing agent in Madagascar. The absence of Phase I, II, or III trials means there are no measured clinical outcomes, effect sizes, or patient population data available. Ethnobotanical surveys and qualitative phytochemical studies form the entire published evidence base, making it impossible to assign confidence intervals or therapeutic equivalence scores. Until controlled human studies are undertaken, clinical use of Voafotsy extracts remains unsupported by evidence-based medicine standards and should be treated as investigational.

Safety & Interactions

No formal safety studies, toxicology reports, or adverse event data have been published for Pterocarpus tinctorius in humans or animals, meaning its safety profile at any dose is currently uncharacterized. Based on its phytochemical composition, general class-level cautions apply: saponin-rich preparations may cause gastrointestinal irritation, nausea, or mucosal disruption at high oral doses, while tannin-rich decoctions consumed chronically could theoretically impair iron absorption through chelation. No drug interaction studies exist; however, polyphenol-rich plant extracts as a class carry theoretical risk of interference with cytochrome P450 enzymes (particularly CYP3A4 and CYP2C9), potentially altering metabolism of anticoagulants, antiretrovirals, or immunosuppressants. Pregnant and lactating individuals should avoid use given the complete absence of reproductive safety data, and individuals with known legume or Fabaceae family allergies should exercise caution given P. tinctorius membership in this botanical family.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Pterocarpus tinctoriusVoafotsyDye pterocarpusMninga majiMubvamaropa

Frequently Asked Questions

What is Voafotsy used for traditionally?
Voafotsy (Pterocarpus tinctorius) is used primarily in Malagasy and broader sub-Saharan African traditional medicine to treat infected wounds, skin inflammations, and parasitic conditions. Bark and heartwood preparations—typically as decoctions or topical washes—are applied to lesions to reduce microbial colonization and promote tissue repair, based on generations of empirical use rather than clinical validation.
What are the active compounds in Pterocarpus tinctorius?
Phytochemical screening of P. tinctorius bark and heartwood identifies phenolic compounds, flavonoids, tannins, stilbenoids, and saponins as the primary bioactive constituents. These compound classes collectively contribute to observed antioxidant, antimicrobial, and astringent properties, though specific compound identities and concentrations unique to this species have not been quantitatively reported in published literature.
Is there scientific evidence that Voafotsy heals wounds?
Current evidence is limited to in vitro laboratory studies showing that methanolic bark extracts of P. tinctorius inhibit bacterial growth, which is consistent with its traditional wound-healing use. No human clinical trials or controlled animal wound-healing studies have been published, so the scientific evidence base remains preliminary and cannot confirm clinical efficacy or optimal dosing for wound care.
Is Voafotsy safe to take as a supplement?
No formal safety or toxicology studies have been conducted on Pterocarpus tinctorius, meaning its safety at any dose in humans is unestablished. Based on its phytochemical profile, saponin and tannin content could cause gastrointestinal irritation at high doses, and potential interactions with drugs metabolized by liver CYP enzymes cannot be excluded; pregnant and lactating individuals should avoid use entirely until safety data are available.
How is Voafotsy prepared for medicinal use?
Traditional preparation involves boiling bark pieces in water to produce a decoction that is either applied topically to wounds or taken orally, or steeping shaved heartwood in hot water as an infusion used as an antiseptic wash. No standardized recipe, concentration, or commercial supplement form exists; all current medicinal use relies on empirical community knowledge without pharmacopoeial standardization.
Does Voafotsy interact with common wound care medications or antibiotics?
While Voafotsy's tannins and phenolic compounds support natural antimicrobial activity, there is limited clinical data on interactions with prescription antibiotics or topical wound treatments. It is advisable to inform healthcare providers if using Voafotsy alongside medicated wound care, as tannins may potentially affect absorption of certain oral medications. Concurrent use with professional medical treatments should be discussed with a healthcare practitioner to ensure complementary rather than conflicting approaches.
What is the most effective form of Voafotsy for wound healing—bark extract, powder, or decoction?
Methanolic and aqueous bark extracts show the strongest antimicrobial activity in laboratory studies, making concentrated extract forms potentially more bioavailable than whole-plant powders. Traditional decoctions (simmered bark tea) provide bioactive tannins and phenolics but with lower concentration than standardized extracts. The choice between forms depends on intended use—topical applications may benefit from concentrated extracts, while oral preparations may utilize decoctions or capsulized powders for systemic support.
Is Voafotsy appropriate for children or should certain populations avoid it?
Safety data for Voafotsy in pediatric populations is limited, and high tannin content may cause digestive sensitivity in young children or those with sensitive stomachs. Pregnant and nursing women should consult healthcare providers before use, as traditional safety during these periods has not been formally established in clinical trials. Individuals with tannin sensitivity, iron deficiency anemia, or those taking iron supplements should exercise caution, as high tannin intake may impair mineral absorption.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.